Latest news
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTIntegrated nanomaterials offer new strategies for cancer immunotherapy - News-MedicalNews-Medical · Mon, 10 Aug 2026 02:50:00 GMTLatigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs - MedCity NewsMedCity News · Sun, 09 Aug 2026 22:02:34 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMTIsraeli study: Viagra may help prevent the spread of cancerous tumors - The Jerusalem PostThe Jerusalem Post · Sun, 09 Aug 2026 05:00:00 GMTDrugs for common eye condition could be used to treat cancer, experts say - The IndependentThe Independent · Sat, 08 Aug 2026 11:37:00 GMTScientists identify which cancer patients would respond well to glaucoma drugs - The Institute of Cancer Research (ICR)The Institute of Cancer Research (ICR) · Sat, 08 Aug 2026 07:45:26 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingViewTradingView · Sat, 08 Aug 2026 00:31:00 GMT